Followers | 54 |
Posts | 3404 |
Boards Moderated | 0 |
Alias Born | 05/01/2017 |
Wednesday, August 09, 2017 12:55:16 AM
(08/08/2017) $ACGX
SHARE STRUCTURE:
OS - 1,539,196,368
Current PPS - .0022
MARKET CAP - $3,386,232
REVENUE & NET PROFIT
Q2 Sales - $4,733,909
2017 YTD Sales - $9,851,345
Q2 Net Profit - $232,438
2017 YTD Net Profit - $507,624
On pace for 20 million revenue this year with over a Million of Net Profit. Market cap at 3.3 million and huge reduction in debt. Basically only good debt left. Balance sheet is completely turned around in the last 12 months, and looks very solid here. I see Nasdaq companies with way worse balance sheets.
One of the best parts here is the Current Asset/Current Liabilities Ratio. Find me an OTC stock with ratio over 1.0 like here, and I'll shake your hand and BUY it!
ASSETS:
CONVERTIBLE DEBT
June 2017
Vs
June 2016
PEOPLEVINE
https://ventureconnects.com
We have an Investment group doing lots of DD on PeopleVine, looking for a huge investment here possibly. Check their website out and it clearly shows they are looking to invest in PeopleVine, and find others to join.
Check the link out, and do your DD on this investment group too.
https://ventureconnects.com/page/investors
Their website is already powered by PeopleVine.
MARKETSIZE
Recent ACGX News
- Alliance Creative Group (ACGX) Releases 2023 Annual Financial and Disclosure Report - PeopleVine's revenue increased by 100% in 2023 • InvestorsHub NewsWire • 04/01/2024 12:00:00 PM
- Alliance Creative Group (ACGX) Reports Third Quarter of 2023 Financials • InvestorsHub NewsWire • 11/15/2023 01:00:00 PM
- Alliance Creative Group (ACGX) Reports Second Quarter of 2023 Financials • InvestorsHub NewsWire • 08/14/2023 08:30:00 PM
- Alliance Creative Group (ACGX) Becomes an Equity Partner of the Coastal Spritz Brand • InvestorsHub NewsWire • 06/13/2023 12:00:00 PM
- Alliance Creative Group (ACGX) Reports First Quarter of 2023 Financials with Over $4,000,000 in assets • InvestorsHub NewsWire • 05/15/2023 12:30:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM